Inventor · disambiguated record
Brian Andrew Stearns
Also filed as: STEARNS BRIAN · STEARNS BRIAN A · STEARNS BRIAN ANDREW
36 granted patents·16 pending applications·196 citations·filing 2002–2023
97Inventor score
Files withAMIRA PHARMACEUTICALS INC11HUTCHINSON JOHN HOWARD8MERCK & CO INC6PANMIRA PHARMACEUTICALS LLC6TEMPEST THERAPEUTICS INC3
Top patents by PatentIndex Score
52 records- 0191US8338484B2N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptorsHUTCHINSON JOHN HOWARD·Filed 2011·Granted Dec 25, 2012·11 cites·10 claims
- 0291US8067445B2N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptorsHUTCHINSON JOHN HOWARD·Filed 2009·Granted Nov 29, 2011·14 cites·31 claims
- 0389US8664220B2Polycyclic compounds as lysophosphatidic acid receptor antagonistsCLARK RYAN·Filed 2010·Granted Mar 4, 2014·17 cites·4 claims
- 0489US8362044B2N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2011·Granted Jan 29, 2013·11 cites·21 claims
- 0589US8217066B2Compounds as lysophosphatidic acid receptor antagonistsSEIDERS THOMAS JON·Filed 2010·Granted Jul 10, 2012·14 cites·16 claims
- 0689US8168678B2N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptorsHUTCHINSON JOHN HOWARD·Filed 2009·Granted May 1, 2012·8 cites·7 claims
- 0788US8071807B2Antagonists of prostaglandin D2 receptorsHUTCHINSON JOHN HOWARD·Filed 2009·Granted Dec 6, 2011·10 cites·23 claims
- 0888US7977359B25-lipdxygenase-activating protein (FLAP) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2006·Granted Jul 12, 2011·11 cites·12 claims
- 0987US8242145B2Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptorsHUTCHINSON JOHN HOWARD·Filed 2009·Granted Aug 14, 2012·14 cites·17 claims
- 1086US7462619B2Pyridazine, pyrimidine and pyrazine ethyne compoundsMERCK & CO INC·Filed 2005·Granted Dec 9, 2008·5 cites·2 claims
- 1184US8778983B2Polycyclic compounds as lysophosphatidic acid receptor antagonistsCLARK RYAN·Filed 2010·Granted Jul 15, 2014·7 cites·9 claims
- 1283US8501959B2Cycloalkane[B]indole antagonists of prostaglandin D2 receptorsHUTCHINSON JOHN HOWARD·Filed 2009·Granted Aug 6, 2013·6 cites·11 claims
- 1383US8426449B2Aminoalkylphenyl antagonists of prostaglandin D2 receptorsHUTCHINSON JOHN HOWARD·Filed 2009·Granted Apr 23, 2013·6 cites·17 claims
- 1483US8399666B25-lipoxygenase-activating protein (FLAP) inhibitorsHUTCHINSON JOHN H·Filed 2006·Granted Mar 19, 2013·10 cites·5 claims
- 1582US8497381B2Antagonists of prostaglandin D2 receptorsHUTCHINSON JOHN HOWARD·Filed 2009·Granted Jul 30, 2013·6 cites·17 claims
- 1682US8383654B2Heterocyclic antagonists of prostaglandin D2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2009·Granted Feb 26, 2013·6 cites·18 claims
- 1779US2024041837A1Triazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1877US9090573B2Compounds as lysophosphatidic acid receptor antagonistsSEIDERS THOMAS J·Filed 2010·Granted Jul 28, 2015·6 cites·4 claims
- 1977US8049015B2Heteroaryl antagonists of prostaglandin D2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2009·Granted Nov 1, 2011·3 cites·36 claims
- 2077US7910561B2Inhibitors of Akt activityMERCK SHARP & DOHME·Filed 2005·Granted Mar 22, 2011·3 cites·4 claims
- 2175US7919621B2Tricyclic inhibitors of 5-lipoxygenaseAMIRA PHARMACEUTICALS INC·Filed 2007·Granted Apr 5, 2011·2 cites·11 claims
- 2274US10568871B2Triazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2017·Granted Feb 25, 2020·1 cites·20 claims
- 2374US9676754B2Triazolone compounds and uses thereofINCEPTION 2 INC·Filed 2013·Granted Jun 13, 2017·2 cites·18 claims
- 2474US7087601B2Metabotropic glutamate receptor-5 modulatorsMERCK & CO INC·Filed 2002·Granted Aug 8, 2006·8 cites·11 claims
- 2573US7365074B2Pyridazine, pyrimidine and pyrazine ethyne compoundsMERCK & CO INC·Filed 2004·Granted Apr 29, 2008·5 cites·2 claims
- 2671US10000456B2Polycyclic compounds as lysophosphatidic acid receptor antagonistsAMIRA PHARMACEUTICALS INC·Filed 2014·Granted Jun 19, 2018·1 cites·13 claims
- 2770US9624182B2Compounds as lysophosphatidic acid receptor antagonistsAMIRA PHARMACEUTICALS INC·Filed 2015·Granted Apr 18, 2017·1 cites·13 claims
- 2870US7105533B2Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulatorsMERCK & CO INC·Filed 2003·Granted Sep 12, 2006·6 cites·12 claims
- 2969US11666557B2Triazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2019·Granted Jun 6, 2023·0 cites·19 claims
- 3069US9505728B2Triazolone compounds and uses thereofINCEPTION 2 INC·Filed 2013·Granted Nov 29, 2016·2 cites·25 claims
- 3159US2013158036A1N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 3257US9572785B2DP2 antagonist and uses thereofBRICKELL BIOTECH INC·Filed 2014·Granted Feb 21, 2017·0 cites·13 claims
- 3355US2024261414A1Fatty acid amide hydrolase (faah) cleavable prodrugs of brain targeting actives and combination with peripherally restricted faah inhibitorsAUTOBAHN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3454US8034826B2Cycloalkane[B]azaindole antagonists of prostaglandin D2 receptorsPANMIRA PHARMACEUTICALS LLC·Filed 2009·Granted Oct 11, 2011·0 cites·12 claims
- 3554US2024254075A1Fatty acid amide hydrolase (faah) cleavable prodrugs of thyromimetics and combination with peripherally restricted faah inhibitorsAUTOBAHN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3651US2010298368A1Antagonists of pgd2 receptorsAMIRA PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3751US2010280049A1Antagonists of pgd2 receptorsAMIRA PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3851US2011098352A1N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptorsAMIRA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3950US8815917B2DP2 antagonist and uses thereofBRITTAIN JASON EDWARD·Filed 2010·Granted Aug 26, 2014·0 cites·5 claims
- 4050US2011112134A1Tricyclic Antagonists of Prostaglandin D2 ReceptorsAMIRA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4148US2011118315A15-lipoxygenase-activating protein (flap) inhibitorsHUTCHINSON JOHN H·Filed 2011·Application pending·0 cites
- 4245US9688624B2DP2 antagonist and uses thereofBRITTAIN JASON EDWARD·Filed 2011·Granted Jun 27, 2017·0 cites·11 claims
- 4345US2007219206A15-lipoxygenase-activating protein (flap) inhibitorsAMIRA PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4445US2021363152A1Aminoazine amidesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 4544US2011112106A1Tricyclic inhibitors of 5-lipoxygenaseAMIRA PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 4643US7687541B2Prodrugs of diaryl-2-(5H)-furanone cyclooxygenase-2 inhibitorsMERCK & CO INC·Filed 2004·Granted Mar 30, 2010·0 cites·18 claims
- 4741US7465730B2Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compoundsMERCK & CO INC·Filed 2003·Granted Dec 16, 2008·0 cites·3 claims
- 4839US2010173313A1Biomarkers of inflammationAMIRA PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4936US2013005721A1Indolizine inhibitors of 5-lipoxygenasePANMIRA PHARMACEUTICALS LLC·Filed 2010·Application pending·0 cites
- 5035US9187439B2Tricyclic compounds useful as neurogenic and neuroprotective agentsINCEPTION 1 INC·Filed 2012·Granted Nov 17, 2015·0 cites·8 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Brian Andrew Stearns files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →